Xconomy National

Archives

by in

Entry	Author	Date	Location
Eli Lilly CEO John Lechleiter on Tackling the Pharmaceutical R&D Crisis (Part 2)	Luke Timmerman	11/22/11	National
Rempex Raises $67.5M, Vertex Shares Tumble, & More San Diego Life Sciences News	Bruce V. Bigelow	11/10/11	San Diego
Amylin Buoyed by Diabetes Trials, Vital Therapies Raises $22.6M, Acutus Medical Gets Seed Cash, & More San Diego Life Sciences News	Bruce V. Bigelow	06/30/11	San Diego
Shire Pays $750M for Advanced BioHealing, Amylin Sues Lilly, Pacira CEO Describes His Most Difficult Task, & More San Diego Life Sciences News	Bruce V. Bigelow	05/19/11	San Diego
Amylin Sues Eli Lilly, Arguing Breach of Contract in Marketing Rival Diabetes Drug	Luke Timmerman	05/16/11	San Diego
Amylin, Lilly, Alkermes Diabetes Drug Doesn’t Match Rival in Head-to-Head Study	Ryan McBride	03/03/11	Boston
Diagnostics Are Warming Up in Era of Fast, Cheap Sequencing, Says MDV’s Rowan Chapman	Luke Timmerman	02/07/11	San Francisco
Amylin Keeps Its Chin Up After A Rough 2010 With New Diabetes Drug	Luke Timmerman	01/21/11	San Diego
John Mendlein Tries His Hand as a ‘Parallel Entrepreneur,’ Santaris Continues RNA Therapeutics Work for Pfizer, & More San Diego Life Sciences News	Bruce V. Bigelow	01/06/11	San Diego
Intarcia Bets It Will Shake Up Diabetes Treatment With Implantable Device	Luke Timmerman	11/29/10	San Francisco
Amylin, Alkermes Eagerly Await FDA Verdict (Again) For Once-Weekly Diabetes Drug	Luke Timmerman	10/15/10	San Diego
Orexigen Drug Shows Potential as “Two-Fer” Against Obesity and Diabetes	Luke Timmerman	06/25/10	San Diego
West Wireless Names CEO, Amylin Pharmaceuticals Awaits FDA Deadline, Life Technologies In Cancer Research Partnership, & More San Diego Life Sciences News	Denise Gellene	03/11/10	San Diego
Amylin Braces for Big Event of 2010, the (Hoped-For) Approval of Once-Weekly Diabetes Drug	Luke Timmerman	01/22/10	San Diego
Amylin Strikes $1 Billion Deal with Takeda to Co-Develop Weight Loss Drugs	Luke Timmerman	11/02/09	San Diego
Amylin, Lilly’s Byetta Wins FDA Approval as Standalone Therapy, Without Combo Drugs	Luke Timmerman	10/30/09	San Diego
Diabetes drug from San Diego’s Amylin caught up in Aussie Brouhaha	Denise Gellene	10/27/09	San Diego
Amylin CEO, Putting Boardroom Coup Behind Him, Turns Up Heat on New Diabetes Drug	Luke Timmerman	09/29/09	San Diego
Aileron Snags $40M From Quartet of Pharma Giants to Develop New Class of Drugs	Luke Timmerman	06/08/09	Boston
Amylin’s Would-Be Savior, Once-Weekly Diabetes Shot, Shows Two-Year Benefit	Luke Timmerman	06/07/09	San Diego
Amylin Founder Ted Greene, In Exclusive Interview, Upbeat About Outcome of Proxy Battle	Bruce V. Bigelow	06/02/09	San Diego
Amylin Chairman, Lead Director Ousted as Dissidents Gain Two Board Seats	Luke Timmerman	06/02/09	San Diego
Amylin’s Dissident Shareholders Gain Influence on Board	Bruce V. Bigelow	05/27/09	San Diego
Amylin Shareholders Vote Today in Battle to Influence Board	Bruce V. Bigelow	05/27/09	San Diego
Amylin Dissidents Ought to Win Proxy Fight, Influential Advisory Firm Says	Luke Timmerman	05/15/09	San Diego
Amylin Co-Founder Sides with Rebels in Proxy Fight	Juha-Pekka Tikka	05/12/09	San Diego
Vical Developing Vaccine for Swine Flu, Acadia’s Stock Almost Doubles on Biovail Deal, Qualcomm Launches Business Plan Contest, & Other San Diego BizTech News	Bruce V. Bigelow	05/11/09	San Diego
Diabetes Drug Application May Be New Factor in Amylin Proxy Battle	Juha-Pekka Tikka	05/05/09	San Diego
Amylin Cuts 200 Sales Reps, Looks for $45M in Savings Next Year	Bruce V. Bigelow	05/04/09	San Diego
Icahn Aiming for Amylin Sale to Eli Lilly	Ryan McBride	04/20/09	San Diego
Page 1 of 2	next page »